BioGeneric Pharma S.A.E

About BioGeneric Pharma S.A.E

BioGeneric Pharma S.A.E (BGP) is an international company whose principle activities are the development, production, analysis and marketing of biopharmaceuticals products and vaccines.BGP is a new “State of the Art” biopharmaceutical manufacturing facility located in the 10th of Ramadan Industrial City, Egypt. The Plant has been designed and constructed / equipped with the latest technologies to conform to International Standards of current Good Manufacturing Practice (cGMP) in compliance with US FDA, EMA and WHO requirements for the manufacture of sterile biopharmaceutical products and vaccines.
BGP was selected to be one of the Recipients of mRNA technology from the WHO mRNA technology transfer hub to build capacity in low- and middle-income countries to produce mRNA vaccines through a center of excellence and training.

LinkedIn Profile:
https://www.linkedin.com/company/biogeneric-pharma/

  • EG
  • 2022
    On CPHI since
  • 250 - 499
    Employees
Company types
Biopharmaceutical company
Primary activities
Biopharmaceutical
Contact info
Meet us at

CPHI Frankfurt 2022

Messe Frankfurt, Germany
1-3 November 2022